PHRRF (PharmaTher Holdings) EBITDA Margin %: 0.00% (As of Feb. 2026)


What is PharmaTher Holdings EBITDA Margin %?

PharmaTher Holdings PHRRF +4.74% EBITDA Margin % is 0.00% as of Feb. 2026. The stock has 2 warning signs investors should review. Among 945 Biotechnology companies, PharmaTher Holdings ranks worse than 105820% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PharmaTher Holdings's EBITDA for the three months ended in Feb. 2026 was $-0.16 Mil. PharmaTher Holdings's Revenue for the three months ended in Feb. 2026 was $0.00 Mil. Therefore, PharmaTher Holdings's EBITDA margin for the quarter that ended in Feb. 2026 was 0.00%.

PharmaTher Holdings  (OTCPK:PHRRF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

PharmaTher Holdings EBITDA Margin % Related Terms

PharmaTher Holdings EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for PharmaTher Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaTher Holdings EBITDA Margin % Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23 May24 May25
EBITDA Margin %
0.00 0.00 0.00 0.00 0.00

PharmaTher Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PHRRF vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, PharmaTher Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaTher Holdings EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's EBITDA Margin % falls into.


PharmaTher Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PharmaTher Holdings's EBITDA Margin % for the fiscal year that ended in May. 2025 is calculated as

EBITDA Margin %=EBITDA (A: May. 2025 )/Revenue (A: May. 2025 )
=-1.131/0
= %

PharmaTher Holdings's EBITDA Margin % for the quarter that ended in Feb. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=-0.155/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
PharmaTher Holdings (PHRRF) has a EBITDA Margin % of 0.00% as of Feb. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PharmaTher Holdings and its competitors. According to the industry distribution chart, PharmaTher Holdings ranks #999999 out of 945 companies in the Biotechnology industry.
Is PharmaTher Holdings' EBITDA Margin % too high?
PharmaTher Holdings' current EBITDA Margin % is 0.00%. Based on the distribution chart, PharmaTher Holdings ranks #999999 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does PharmaTher Holdings' EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PharmaTher Holdings ranks #999999 out of 945 companies for EBITDA Margin %. This places PharmaTher Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PharmaTher Holdings and its competitors. PharmaTher Holdings's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaTher Holdings stock overvalued right now?
PharmaTher Holdings (PHRRF) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PharmaTher Holdings (PHRRF), the current EBITDA Margin % is 0.00% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaTher Holdings Business Description

Other Exchanges NCC0:GermanyPHRM:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch and others.